Latest Strategic Leadership News

Select Harvests appoints Kristina Hermanson as Managing Director and CEO, aiming to leverage her 25 years of global agribusiness expertise to drive the company’s next growth phase.

Rokeby Resources appoints Richard Beazley as Managing Director and Tim Pallas as Chairman, signalling a strategic leadership overhaul to support the acquisition and development of the high-grade Omeo Gold Project in Victoria.

Argent Minerals appoints mining veteran Mike McKevitt as CEO to spearhead advancement of its flagship Kempfield Silver Project and evaluate growth across gold and copper assets.

Hawk Resources has dispatched materials for a $1.97 million non-renounceable entitlement offer priced at 3 cents per share, offering shareholders free options and a chance to apply for shortfall shares.

Minbos Resources has secured a crucial milestone by signing the final security agreement for its US$16 million IDC loan and submitting a first drawdown request of US$4.8 million to fund ongoing construction at Cabinda.

BCAL Diagnostics has embedded referral forms for its early cancer detection tests into clinical software used by 97% of Australian GPs, launched a telehealth platform, and opened a Sydney clinic, gearing up for a multi-cancer test launch in June 2026.

ASX has appointed Anthony Attia as its next Managing Director and CEO, bringing nearly 30 years of global exchange experience to guide the company through its ongoing transformation.

Pathkey.AI appoints Andrew Farnsworth as CEO, leveraging his defence and AI expertise to drive commercialisation of TrialKey and Chipforge platforms.

Kingsrose Mining has appointed Andrew Caruso as its new CEO, bringing over three decades of mining leadership experience to drive its Scandinavian projects and acquisition strategy. His remuneration package includes a base salary of CND$400,000 plus performance-linked incentives tied to share price milestones.

Murray Cod Australia (ASX:MCA) is raising $18.6 million through a fully underwritten entitlement offer at a steep 43% discount to last price, aiming to convert its record 3,700-tonne biomass into sales and expand processing capacity.

Alterity Therapeutics secures FDA backing on key Phase 3 elements for ATH434 in Multiple System Atrophy, bolstered by fresh Phase 2 data showing slowed disease progression and strategic leadership hires.

Yari Minerals has lifted its total coal resource at Rolleston South to approximately 223 million tonnes, including a maiden indicated resource of 33.7 million tonnes. The project’s shallow coal seams and strong quality underpin potential open-cut mining and export opportunities.